Filter by: Subject

Results Per Page:

Filter by: Subject

177Lu-PSMA (1)
18F- (1)
18F-FDG (1)
18F-FDG imaging (1)
18F-fluorodeoxyglucose (18F-FDG) (1)
18Ffluorodeoxyglucose (FDG) (1)
195mPt-cisplatinum (1)
2-Fluorodeoxy-D-glucose imaging (1)
2-fluorodeoxyglucose positron emission tomography integrated with CT (FDG-PET/CT) (1)
68Ga labeling (1)
68Ga-citrate (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMA (2)
68Ga-PSMA PET/CT (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
99mTc after-hours supply (1)
99mTc clinical supply chain (1)
99mTc clinical wastage (1)
99mTc ordering (1)
99mTc syringe utilization (1)
Accountability (1)
Active ingredients (1)
Adult (1)
AIDS (Disease) (1)
Allergic reactions (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (2)
Antifungal therapy (1)
Antimicrobial peptide (AMP) (4)
Aspergillus (1)
Babesiosis (1)
Bacteria (1)
Bacterial infection (1)
Bacterial infections (1)
Bacteriaspecific imaging (1)
Behandlung (1)
Bins (1)
Bioassay (1)
Biodistribution (1)
Biological evaluation (1)
Biologival evaluation (1)
Biomaterials (1)
Bisphosphonates (1)
Black South-African (BSAs) (1)
Blood-brain barrier (1)
Blood-brain barrier (BBB) (1)
Blood–brain barrier (BBB) (1)
Bone metastases (1)
Bone scintigraphy (1)
Bone SPECT-CT (1)
Breast cancer (3)
Breast uptake (1)
Brown adipose tissue (BAT) (1)
Brown fat (1)
Burkitt lymphoma (BL) (1)
Calcium (1)
Calcium homeostasis (1)
Cancer (3)
Cancer -- Patients -- Care (1)
Candida (1)
Canine babesiosis (1)
Capillary electrophoresis–mass spectrometry (CE-MS) (1)
CAS 82626-48-0 (1)
Case report (2)
Cathelicidin (1)
Cavernous sinus syndrome (1)
CDP1 (1)
Cervical cancer (1)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)
Chemotherapy -- Research -- South Africa (1)
Chromatography (1)
Chronic kidney disease-mineral and bone disorder (1)
Cisplatin (1)